Crossflo owners lost more than $ 2,5mio since the completion of the merger

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Crossflo owners lost more than $ 2,5mio since the completion of the merger

posted on Oct 16, 2008 01:19PM

"The average closing price of our common stock as required to be calculated in the Agreement and Plan of Merger was $0.24389 per share."

I wonder, what the former Crossflo owner think about the merger, if they look at their PTSC account in the last weeks...;-))

Or are they relaxed, because they know, what PTSC and their company is going to accomplish in the next time?

Just nine trading days until the Shareholder Meeting - will something positive happen until then?